Butamirate (citrate)
Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma[1][2].
Product Specifications
CAS Number
18109-81-4
Product Name Alternative
CS-505
UNSPSC
12352005
Target
STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/butamirate-citrate.html
Purity
99.88
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(OCCOCCN(CC)CC)C(CC)C1=CC=CC=C1.O=C(CC(C(O)=O)(O)CC(O)=O)O
Molecular Formula
C24H37NO10
Molecular Weight
499.55
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF740 conjugate, 0.1mg/mL
Thymidylate Synthase (TS106), CF740 conjugate, 0.1mg/mL
